We then examined whether LRRK2 and Parkin recruitment to damaged mitochondria was impaired in 7 fibroblast lines of FTLD and parkinsonism patients or at-risk individuals with MAPT mutations, obtained from the NINDS human and cell repository (Figure 1B; Supplementary Table 1). This evidence concerns the gene PRKN and Parkinson disease.